Unichem Laboratories Stock Screener | Share Price & Fundamental Analysis
UNICHEMLAB
Pharmaceuticals
Share Price NSE
₹329.30
▲
15.40 (4.91%)
Share Price BSE
₹329.85
▲
15.80 (5.03%)
Track Unichem Laboratories share price live with TickJournal's free stock screener.
Analyze Unichem Laboratories share price history trends and compare 52-week high low
levels.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Unichem Laboratories Market Cap
₹2,100.20 Cr.
UNICHEMLAB P/E Ratio (TTM)
7.15
Unichem Laboratories P/B Ratio
0.87
EPS (TTM)
₹19.53
Dividend Yield
-
Debt to Equity
0.14
UNICHEMLAB 52 Week High
₹647.55
Unichem Laboratories 52 Week Low
₹284.05
Operating Margin
9.00%
Profit Margin
32.63%
UNICHEMLAB Revenue (TTM)
₹809.00
EBITDA
₹332.00
Net Income
₹264.00
Total Assets
₹3,569.00
Total Equity
₹2,451.00
Unichem Laboratories Share Price History - Stock Screener Chart
Screen UNICHEMLAB historical share price movements with interactive charts. Analyze price trends and patterns.
Unichem Laboratories Company Profile - Fundamental Screener
Screen Unichem Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for UNICHEMLAB shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE351A01035
Unichem Laboratories Balance Sheet Screener
Screen UNICHEMLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 3,569 | 3,275 | 3,193 | 3,319 | 3,126 | 3,145 | 3,150 | 3,194 | 1,527 | 1,284 |
| Current Assets | 2,030 | 1,743 | 1,589 | 1,648 | 1,377 | 1,687 | 2,038 | 2,337 | 749 | 600 |
| Fixed Assets | 1,300 | 1,252 | 1,257 | 990 | 884 | 870 | 810 | 578 | 491 | 403 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 127 | 99 | 118 | 148 | 63 | 47 | 27 | 50 | 70 | 86 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 2,451 | 2,438 | 2,435 | 2,618 | 2,557 | 2,531 | 2,620 | 2,680 | 1,064 | 954 |
| Share Capital | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 18 | 18 |
| Reserves & Surplus | 2,437 | 2,424 | 2,421 | 2,604 | 2,543 | 2,517 | 2,606 | 2,666 | 1,045 | 936 |
Unichem Laboratories Income Statement Screener - Profit & Revenue Analysis
Screen Unichem Laboratories income statement and profit fundamentals.
Analyze UNICHEMLAB quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Unichem Laboratories share price evaluation.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Mar | 2022-Jun | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 809 | 600 | 533 | 596 | 547 | 516 | 487 | 438 | 545 | 421 | 432 | 407 | 384 | 318 | 338 |
| Expenses | 476 | 571 | 504 | 504 | 448 | 452 | 443 | 532 | 435 | 407 | 395 | 419 | 302 | 311 | 352 |
| EBITDA | 332 | 29 | 29 | 93 | 99 | 64 | 44 | -94 | 110 | 14 | 37 | -12 | 83 | 7 | -14 |
| Operating Profit % | 9.00% | 1.00% | 4.00% | 14.00% | 16.00% | 11.00% | 8.00% | -23.00% | 7.00% | 2.00% | 7.00% | -4.00% | 19.00% | 0.00% | -7.00% |
| Depreciation | 31 | 32 | 32 | 30 | 31 | 32 | 32 | 27 | 32 | 30 | 29 | 30 | 23 | 25 | 28 |
| Interest | 7 | 8 | 7 | 6 | 7 | 5 | 4 | 5 | 6 | 7 | 6 | 6 | 2 | 3 | 5 |
| Profit Before Tax | 293 | -11 | -9 | 58 | 62 | 27 | 8 | -126 | 73 | -22 | 2 | -47 | 58 | -21 | -47 |
| Tax | 29 | 1 | 1 | 5 | 4 | 3 | 6 | 3 | 0 | 3 | 3 | -3 | -14 | 3 | 23 |
| Net Profit | 264 | -12 | -11 | 53 | 58 | 25 | 2 | -129 | 73 | -25 | -1 | -44 | 72 | -23 | -71 |
| EPS | 37.54 | -1.69 | -1.49 | 7.52 | 8.22 | 3.50 | 0.29 | -18.37 | 10.39 | -3.48 | -0.09 | -6.28 | 10.15 | -3.32 | -10.04 |
Unichem Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen UNICHEMLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -7 | 14 | -85 | -260 | 33 | 20 | -328 | -112 | 68 | 112 |
| Investing Activities | -242 | 63 | 241 | 100 | -66 | -36 | -286 | 1,648 | -128 | -85 |
| Financing Activities | 184 | -106 | -81 | 191 | -121 | -62 | -2 | -881 | 59 | -33 |
| Net Cash Flow | -65 | -29 | 75 | 32 | -154 | -78 | -616 | 655 | -1 | -7 |
Unichem Laboratories Shareholding Pattern Screener
See Unichem Laboratories shareholding pattern with promoter, FII, and DII holdings.
Check Unichem Laboratories promoter holding and ownership changes for UNICHEMLAB on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% | 70.22% |
| FII Holding | 0.98% | 0.98% | 1.00% | 0.99% | 0.90% | 0.89% | 0.94% | 1.06% |
| DII Holding | 11.32% | 10.92% | 10.75% | 10.74% | 11.27% | 11.58% | 11.67% | 11.63% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 14.80% | 15.16% | 15.26% | 15.18% | 15.12% | 14.80% | 14.58% | 14.47% |
| Other Holding | 2.67% | 2.72% | 2.77% | 2.86% | 2.49% | 2.50% | 2.60% | 2.62% |
| Shareholder Count | 21,621 | 23,010 | 23,577 | 23,267 | 21,171 | 20,621 | 20,374 | 21,472 |
Unichem Laboratories Share Dividend Screener - Share Yield Analysis
Check Unichem Laboratories dividend history with payout and yield data.
View Unichem Laboratories dividend details including ex-dates and amounts for UNICHEMLAB stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹4.00 | 0.81% |
| 2022-March | ₹4.00 | 1.39% |
| 2021-March | ₹4.00 | 1.54% |
| 2020-March | ₹4.00 | 1.29% |
| 2019-March | ₹4.00 | 2.57% |
| 2018-March | ₹5.00 | 2.57% |
| 2017-March | ₹3.00 | 1.05% |
Unichem Laboratories Stock Index Membership
See which indices include Unichem Laboratories stock.
Check UNICHEMLAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
Unichem Laboratories Market Events Screener - Corporate Actions
Get Unichem Laboratories corporate actions including splits, bonuses, and buybacks.
Check Unichem Laboratories stock events that may affect UNICHEMLAB share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-02-05 | 2026-02-05 | Quarterly Result Announcement | NA | -1.58% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | -1.98% |
| 2025-08-04 | 2025-08-04 | Quarterly Result Announcement | NA | 0.42% |
| 2025-08-04 | 2025-08-04 | Annual General Meeting | NA | 6.72% |
| 2025-05-22 | 2025-05-22 | Quarterly Result Announcement | NA | 7.30% |
| 2025-02-06 | 2025-02-06 | Quarterly Result Announcement | NA | 7.03% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | 9.30% |
| 2024-08-08 | 2024-08-08 | Annual General Meeting | NA | 8.44% |
| 2022-08-01 | 2022-08-03 | Dividend | ₹ 4.00 /share | 26.80% |
| 2021-07-22 | 2021-07-26 | Dividend | ₹ 4.00 /share | -7.27% |
Unichem Laboratories Competitors Screener - Peer Comparison
Screen UNICHEMLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 406,351 | 37.86 | 54,729 | 9.71% | 10,980 | 37.98 |
| Divis Laboratories | 155,472 | 63.26 | 9,712 | 18.67% | 2,191 | 33.24 |
| Torrent Pharmaceuticals | 134,945 | 61.20 | 11,539 | 6.99% | 1,911 | 32.75 |
| Lupin | 103,954 | 22.26 | 22,910 | 13.74% | 3,306 | 47.35 |
| Dr Reddys Laboratories | 101,601 | 18.27 | 33,741 | 16.73% | 5,725 | 39.36 |
| Cipla | 96,320 | 21.31 | 28,410 | 7.12% | 5,291 | 26.86 |
| Zydus Life Science | 86,964 | 17.29 | 23,511 | 18.55% | 4,615 | 41.42 |
| Mankind Pharma | 82,499 | 45.81 | 12,744 | 20.90% | 2,007 | 41.40 |
| Aurobindo Pharma | 77,462 | 22.37 | 32,346 | 9.43% | 3,484 | 64.38 |
| Alkem Laboratories | 62,867 | 25.87 | 13,458 | 3.70% | 2,216 | 42.54 |
Unichem Laboratories Company Announcements - News Screener
Screen UNICHEMLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-05 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-03-30 | Closure of Trading Window | - |
| 2026-03-20 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-02-26 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-25 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | - |
| 2026-02-06 | Disclosure Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 | - |
| 2026-02-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-05 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-02-05 | Financial Results | - |
| 2026-02-05 | Board Meeting Outcome for Outcome Of The Board Meeting | - |
| 2026-02-02 | Announce Under Regulation 30 (LODR) - USFDA Inspected The CompanyS Kolhapur API Facility | - |
| 2026-01-27 | Announcement Under Reg. 30 Of Listing Regulations | - |
| 2026-01-27 | Final Report On Re-Lodgement Of Transfer Requests Of Physical Shares From 1St December 2025 Upto 6Th January 2026 | - |
| 2026-01-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-01-09 | Board Meeting Intimation for Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31 2025. | - |
| 2025-12-22 | Closure of Trading Window | - |
| 2025-12-16 | 5Th Report On Re-Lodgement Of Transfer Requests Of Physical Shares For The Month Ended 30Th November 2025. | - |
| 2025-11-17 | 4Th Report On Re-Lodgement Of Transfer Requests Of Physical Shares For The Month Ended 31St October 2025. | - |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-11-11 | Financial Results For Quarter And Half Year Ended 30Th September 2025 | - |